Literature DB >> 29463860

The path to metastatic mouse models of colorectal cancer.

Gabriele Romano1, Sharmeen Chagani1, Lawrence N Kwong2.   

Abstract

The study and comprehension of the molecular mechanisms underlying cancer biology strongly rely on mouse modeling. An ideal mouse model should have molecular, histopathological, and etiological characteristics as close as possible to those of the corresponding human tumors. Among solid tumors, colorectal cancer (CRC) is one of the malignancies that best suits reproduction in an animal model: it evolves through a progressive set of molecular events and is generally associated with a precise histopathology and a neat cataloging of stages and grades. The development of refined CRC mouse models over several decades has seen them recently evolve toward sophisticated systems that ever more closely approximate the human pathology, with different models addressing different human CRC subtypes. In particular, a metastatic CRC model has been seen as a "holy grail" in this field, and we describe in this review the path taken to achieve metastatic models and discuss the path forward.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29463860     DOI: 10.1038/s41388-018-0155-x

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  62 in total

1.  Loss of Apc and the entire chromosome 18 but absence of mutations at the Ras and Tp53 genes in intestinal tumors from Apc1638N, a mouse model for Apc-driven carcinogenesis.

Authors:  R Smits; A Kartheuser; S Jagmohan-Changur; V Leblanc; C Breukel; A de Vries; H van Kranen; J H van Krieken; S Williamson; W Edelmann; R Kucherlapati; R Fodde
Journal:  Carcinogenesis       Date:  1997-02       Impact factor: 4.944

2.  Identification of Mom7, a novel modifier of Apc(Min/+) on mouse chromosome 18.

Authors:  Lawrence N Kwong; Alexandra Shedlovsky; Bryan S Biehl; Linda Clipson; Cheri A Pasch; William F Dove
Journal:  Genetics       Date:  2007-04-15       Impact factor: 4.562

3.  BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status.

Authors:  Shi Yang; Francis A Farraye; Charline Mack; Oksana Posnik; Michael J O'Brien
Journal:  Am J Surg Pathol       Date:  2004-11       Impact factor: 6.394

4.  APC mutations occur early during colorectal tumorigenesis.

Authors:  S M Powell; N Zilz; Y Beazer-Barclay; T M Bryan; S R Hamilton; S N Thibodeau; B Vogelstein; K W Kinzler
Journal:  Nature       Date:  1992-09-17       Impact factor: 49.962

5.  An Msh2 conditional knockout mouse for studying intestinal cancer and testing anticancer agents.

Authors:  Melanie H Kucherlapati; Kyeryoung Lee; Andrew A Nguyen; Alan B Clark; Harry Hou; Andrew Rosulek; Hua Li; Kan Yang; Kunhua Fan; Martin Lipkin; Roderick T Bronson; Linda Jelicks; Thomas A Kunkel; Raju Kucherlapati; Winfried Edelmann
Journal:  Gastroenterology       Date:  2009-11-18       Impact factor: 22.682

6.  TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway.

Authors:  Patty Trobridge; Sue Knoblaugh; M Kay Washington; Nina M Munoz; Karen D Tsuchiya; Andres Rojas; Xiaoling Song; Cornelia M Ulrich; Takehiko Sasazuki; Senji Shirasawa; William M Grady
Journal:  Gastroenterology       Date:  2009-02-04       Impact factor: 22.682

Review 7.  Genomic and epigenetic instability in colorectal cancer pathogenesis.

Authors:  William M Grady; John M Carethers
Journal:  Gastroenterology       Date:  2008-09-04       Impact factor: 22.682

8.  A Big Bang model of human colorectal tumor growth.

Authors:  Andrea Sottoriva; Haeyoun Kang; Zhicheng Ma; Trevor A Graham; Matthew P Salomon; Junsong Zhao; Paul Marjoram; Kimberly Siegmund; Michael F Press; Darryl Shibata; Christina Curtis
Journal:  Nat Genet       Date:  2015-02-09       Impact factor: 38.330

9.  Oncogenic Kras drives invasion and maintains metastases in colorectal cancer.

Authors:  Adam T Boutin; Wen-Ting Liao; Melody Wang; Soyoon Sarah Hwang; Tatiana V Karpinets; Hannah Cheung; Gerald C Chu; Shan Jiang; Jian Hu; Kyle Chang; Eduardo Vilar; Xingzhi Song; Jianhua Zhang; Scott Kopetz; Andrew Futreal; Y Alan Wang; Lawrence N Kwong; Ronald A DePinho
Journal:  Genes Dev       Date:  2017-03-13       Impact factor: 11.361

10.  A genetic progression model of Braf(V600E)-induced intestinal tumorigenesis reveals targets for therapeutic intervention.

Authors:  Roland Rad; Juan Cadiñanos; Lena Rad; Ignacio Varela; Alexander Strong; Lydia Kriegl; Fernando Constantino-Casas; Stefan Eser; Maren Hieber; Barbara Seidler; Stacey Price; Mario F Fraga; Vincenzo Calvanese; Gary Hoffman; Hannes Ponstingl; Günter Schneider; Kosuke Yusa; Carolyn Grove; Roland M Schmid; Wei Wang; George Vassiliou; Thomas Kirchner; Ultan McDermott; Pentao Liu; Dieter Saur; Allan Bradley
Journal:  Cancer Cell       Date:  2013-07-08       Impact factor: 31.743

View more
  13 in total

1.  Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer.

Authors:  Martin Pichler; Cristian Rodriguez-Aguayo; Su Youn Nam; Mihnea Paul Dragomir; Recep Bayraktar; Simone Anfossi; Erik Knutsen; Cristina Ivan; Enrique Fuentes-Mattei; Sang Kil Lee; Hui Ling; Tina Catela Ivkovic; Guoliang Huang; Li Huang; Yoshinaga Okugawa; Hiroyuki Katayama; Ayumu Taguchi; Emine Bayraktar; Rajat Bhattacharya; Paola Amero; William Ruixian He; Anh M Tran; Petra Vychytilova-Faltejskova; Christiane Klec; Diana L Bonilla; Xinna Zhang; Sanja Kapitanovic; Bozo Loncar; Roberta Gafà; Zhihui Wang; Vittorio Cristini; Samir M Hanash; Menashe Bar-Eli; Giovanni Lanza; Ondrej Slaby; Ajay Goel; Isidore Rigoutsos; Gabriel Lopez-Berestein; George Adrian Calin
Journal:  Gut       Date:  2020-01-27       Impact factor: 23.059

2.  CREB1 contributes colorectal cancer cell plasticity by regulating lncRNA CCAT1 and NF-κB pathways.

Authors:  Bin Li; Lisi Zheng; Jiayi Ye; Chenmin Zhang; Jie Zhou; Qiaojuan Huang; Yanhua Guo; Luqin Wang; Peng Yu; Shurong Liu; Qiao Lin; Yuxia Luo; Hui Zhou; Jianhua Yang; Lianghu Qu
Journal:  Sci China Life Sci       Date:  2022-06-10       Impact factor: 10.372

Review 3.  Host-microbiota maladaptation in colorectal cancer.

Authors:  Alina Janney; Fiona Powrie; Elizabeth H Mann
Journal:  Nature       Date:  2020-09-23       Impact factor: 49.962

Review 4.  Outcompeting cancer.

Authors:  Medhavi Vishwakarma; Eugenia Piddini
Journal:  Nat Rev Cancer       Date:  2020-01-13       Impact factor: 60.716

Review 5.  Uncoupling Traditional Functionalities of Metastasis: The Parting of Ways with Real-Time Assays.

Authors:  Sagar S Varankar; Sharmila A Bapat
Journal:  J Clin Med       Date:  2019-06-28       Impact factor: 4.241

Review 6.  The role of mouse models in colorectal cancer research-The need and the importance of the orthotopic models.

Authors:  Rui C Oliveira; Ana Margarida Abrantes; José Guilherme Tralhão; Maria Filomena Botelho
Journal:  Animal Model Exp Med       Date:  2020-03-11

Review 7.  Modeling metastasis in mice: a closer look.

Authors:  Arianna Giacobbe; Cory Abate-Shen
Journal:  Trends Cancer       Date:  2021-07-22

8.  Identification of Eph receptor signaling as a regulator of autophagy and a therapeutic target in colorectal carcinoma.

Authors:  Michael DiPrima; Dunrui Wang; Alix Tröster; Dragan Maric; Nekane Terrades-Garcia; Taekyu Ha; Hyeongil Kwak; David Sanchez-Martin; Denis Kudlinzki; Harald Schwalbe; Giovanna Tosato
Journal:  Mol Oncol       Date:  2019-10-23       Impact factor: 6.603

9.  A novel patient-derived organoids-based xenografts model for preclinical drug response testing in patients with colorectal liver metastases.

Authors:  Mi Jian; Li Ren; Guodong He; Qi Lin; Wentao Tang; Yijiao Chen; Jingwen Chen; Tianyu Liu; Meiling Ji; Ye Wei; Wenju Chang; Jianmin Xu
Journal:  J Transl Med       Date:  2020-06-12       Impact factor: 5.531

10.  Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis.

Authors:  Rene Jackstadt; Sander R van Hooff; Joshua D Leach; Xabier Cortes-Lavaud; Jeroen O Lohuis; Rachel A Ridgway; Valérie M Wouters; Jatin Roper; Timothy J Kendall; Campbell S Roxburgh; Paul G Horgan; Colin Nixon; Craig Nourse; Matthias Gunzer; William Clark; Ann Hedley; Omer H Yilmaz; Mamunur Rashid; Peter Bailey; Andrew V Biankin; Andrew D Campbell; David J Adams; Simon T Barry; Colin W Steele; Jan Paul Medema; Owen J Sansom
Journal:  Cancer Cell       Date:  2019-09-16       Impact factor: 38.585

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.